ADCs, AOCs, ATMPs, cell and gene therapies, and oligonucleotide therapeutics represent distinct but interconnected approaches to precision medicine. Let's take a closer look at their manufacturing needs.
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Accelerating Technology Transfer Of A Drug Product
See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.
-
Ensuring Supply Through Speed And Transparency
Through speed, transparency, and close collaboration, the pharmaceutical company was able to switch vendors seamlessly, maintaining virtually uninterrupted manufacturing operations.
-
Improving Next-Generation Sequencing Workflows With Droplet Digital PCR
Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.
-
Scale-Up Of AAV Production In Fixed-Bed Bioreactors
Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
Three-Dimensional Linkage Analysis With Digital PCR For Genome Integrity
A cost-effective approach with a comprehensive AAV analytical package holds the potential to advance the application of rAAV in cell and gene therapy for the treatment of human diseases.
-
AI Unveils Tumor-Immune Landscape In Colorectal Adenocarcinoma
AI-powered multiplexed imaging and analysis explore the tumor-immune microenvironment in colorectal adenocarcinoma, identifying potential biomarkers for therapeutic insights.
-
Selecting A Central Lab Network For Radiopharmaceutical Readiness
A wave of late-stage radiopharmaceutical trials is straining lab infrastructure concentrated in a handful of academic centers, limiting site diversity, expertise, and trial capacity nationwide.
-
The AI-Ready Factory: How IT/OT Integration Transforms Manufacturing Data
Pharmaceutical manufacturers need more than raw production data to scale AI. Learn how contextualized, governed IT/OT integration can turn disconnected shop-floor signals into real-time decisions.
-
Comparing Nebulized Hydrogen Peroxide (NHP) And Vaporized Hydrogen Peroxide (VHP) For Isolator Decontamination
Compare Nebulized and Vaporized Hydrogen Peroxide efficacy, cycle times, and validation challenges inside pharmaceutical isolators to optimize your aseptic processing turnaround.
NEWSLETTER ARCHIVE
- 11.13.26 -- Closing The CAR-T Access Gap With Hospital-Based Manufacturing
- 11.12.26 -- A New Model For Bringing CAR-T To More Patients
- 11.12.26 -- Simplify The Journey Of Advancing Your Therapies To Patients
- 11.12.26 -- The Latest CDMO Opportunities And Threats Report
- 11.11.26 -- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

